Role of oxidative stress in transition of hypertrophy to heart failure  by Dhalla, Arvinder K. et al.
506 JACC Vol. 28, No. 2 
August 1996:506-14 
Role of Oxidative Stress in Transition of Hypertrophy to 
Heart Failure 
ARVINDER K. DHALLA,  PHD, M ICHAEL  F. HILL, MSc, PAWAN K. SINGAL, PHD, DSc, FACC 
Winnipeg, Manitoba, Canada 
Objectives. In an attempt to define the role of increased 
oxidative stress in the transition from compensatory hypertrophy 
to heart failure, this study examined the effects of long-term 
vitamin E therapy on the occurrence of heart failure subsequent to 
chronic pressure overload in guinea pigs. 
Background. Hyperfunctional heart hypertrophy has been 
shown to be accompanied by an increase in the endogenous 
antioxidant reserve, whereas congestive heart failure is accompa- 
nied by a decrease in this reserve. The effects of vitamin E, a 
naturally occurring antioxidant, on the development of heart 
failure from a hypertrophic stage were examined. 
Methods. The ascending aorta in guinea pigs was coarcted. For 
vitamin treatment, slow-release pellets were implanted at the time 
of the operation. The animals were assessed at 10 and 20 weeks for 
hemodynamic function, myocardial structure, antioxidant agents 
and oxidative stress. 
Results. Banding of the ascending aorta in guinea pigs resulted 
in hyperfunctional hypertrophy at 10 weeks, which was followed by 
congestive heart failure at 20 weeks. Hypertrophied hearts showed 
decreased oxidative stress, as evidenced by a higher oxidation- 
reduction (redox) state and less lipid peroxidation, whereas the 
failure stage was characterized by increased oxidative stress. 
Supplementation of animals with timed-release vitamin E tablets 
resulted in an increased myocardial content of the vitamin, and 
the banded animals did not develop any signs of heart failure at 20 
weeks. Hemodynamic function at 20 weeks in these vitamin 
E-treated animals was also better maintained. The myocardial 
reduced glutathione/oxidized glutathione ratio of vitamin 
E-treated animals at 20 weeks was higher and lipid peroxidation 
was less compared with the untreated animals. Ultrastructural 
abnormalities were significantly less in the vitamin E-treated 
hearts compared with the untreated failing hearts at 20 weeks. 
Conclusions. An improved myocardial redox state with vitamin 
E therapy, coupled with the modulation of the development of 
heart failure, may indicate a pathophysiologic role for increased 
oxidative stress in the pathogenesis of heart failure. This study 
suggests the potential therapeutic value of long-term antioxidant 
treatment in modulating or preventing the pathogenesis of heart 
failure. 
(J Am Coil Cardiol 1996;28:506-14) 
Congestive heart failure has been defined in many different 
ways, and many of these definitions imply it to be "the 
pathophysiological state in which an abnormality of cardiac 
function is responsible for failure of the heart o pump blood 
at a rate commensurate with the demands of the metabolizing 
tissues" (1). Apparently, congestive heart failure is a common 
end point of many abnormal cardiac conditions, including 
hypertrophy. When compensatory mechanisms that become 
activated uring heart hypertrophy fail, congestive heart fail- 
ure is manifested, and this is associated with a grave prognosis. 
Heart failure subsequent to cardiac hypertrophy remains a 
major clinical problem, and the progression of a well- 
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compensated hypertrophied heart o that of a decompensated 
stage is poorly understood. 
It has been shown that an increase in oxidative stress due to 
an increase in free radicals or a relative deficit in the endoge- 
nous antioxidant reserve, or both, can cause contractile dys- 
function (2-4), and this has been suggested as one of the 
contributing factors in the transition of compensated heart 
hypertrophy to the decompensated stage (5). In this regard, 
hyperfunctional heart hypertrophy due to increased cardiac 
work load is associated with increased endogenous antioxidant 
enzyme activities (6-8). These hypertrophied hearts have also 
been found to be less vulnerable to ex vivo as well as in vivo 
oxidative stress conditions induced by free radicals, bypoxia- 
reoxygenation, ischemia-reperfusion injury and doxorubicin- 
induced cardiotoxicity (6,7,9,10). In the hypertrophied hearts, 
reduced oxidative stress was indicated by an increase in the 
ratio of reduced glutathione tooxidized glutathione as well as 
a decrease in lipid peroxidation (7,8). In contrast, heart failure 
due to a variety of conditions has been shown to be associated 
with increased oxidative stress, as indicated by reduced anti- 
oxidants, a depressed oxidation-reduction (redox) state and 
increased lipid peroxidation (7-11). Increased pulmonary pen- 
tane excretion in heart failure patients (12,13) is also viewed as 
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an index of free radical injury and lipid peroxidation (13). 
Although these data from animal as well as patients experi- 
ments suggest a role for increased oxidative stress in the 
pathogenesis of heart failure, a cause and effect relation 
remains to be established. 
Vitamin E is a lipid-soluble, naturally occurring antioxidant 
that helps stabilize biologic membranes by interrupting free 
radical chain reactions, as well as by reducing lipid peroxida- 
tion (14). It has been shown to reduce free radical-mediated 
injury in in vivo conditions (15,16), decrease platelet adhesive- 
ness (17) and limit infarct size (18). Furthermore, animals 
put on a vitamin E-deficient diet were more prone to 
cateeholamine- as well as adriamycin-induced cardiomyopa- 
thies, and both of these conditions are known to be mediated 
by free radical action (19,20). In the present study, the effects 
of long-term antioxidant therapy involving vitamin E on the 
occurrence of heart failure subsequent to a chronic pressure 
overload in guinea pigs were examined to define the role of 
oxidative stress in the transition process from compensated 
hypertrophy toheart failure. 
Methods  
Procedure. Male guinea pigs (25 _+ 3 days old) weighing 
250 _+ 25 g were used in the study. Pressure overload on the 
heart was imposed by surgically narrowing the ascending aorta, 
which has been shown to result in hypertrophy that progresses 
into heart failure (21). Briefly, the animals were anesthetized 
with a single intraperitoneal injection of methohexital sodium 
(35 mg/kg) and placed on positive-pressure v ntilation. Tho- 
racotomy was performed between the second and third inter- 
costal space. The ascending aorta was cleared from the adher- 
ing tissues. A steel wire (16-gauge steel needle) was placed 
along the aorta, and a 3-0 silk thread was gently tied around 
the wire as well as the aorta just above the coronary ostia. The 
wire was then withdrawn, the chest was closed and an antibiotic 
powder (Cicatrin, Burroughs Wellcome, Canada) was applied 
topically. The surgical procedure was carried out under sterile 
conditions. The postoperative mortality rate was < 10%. Sham- 
operated animals were treated in an identical manner, except 
that no band was placed around the aorta. The procedure 
resulted in a marginally constricting band with a cross-sectional 
area (including the lumen as well as the aortic tissue) of 3.6 _+ 
0.02 mm 2. 
Hemodynamic and other measurements. The animals were 
anesthetized with an intraperitoneal injection of methohexital 
(35 mg/kg), and a miniature-tipped pressure transducer cath- 
eter (model PR 249, Millar Instruments) was inserted into the 
right carotid artery and then advanced into the left ventricle. 
Left ventricular peak systolic pressure (LVSP), left ventricular 
end-diastolic pressure (LVEDP), and aortic pressure were 
recorded on a precalibrated multichannel dyanograph (Beck- 
man Instruments). Steady state readings were taken 15 min 
after catheterization. After hemodynamic assessment, the an- 
imals were killed and their hearts were removed for further 
analysis. To obtain the ventricular weight, the atria and other 
adhering tissues were removed. Left ventricular wall thickness 
was measured inheart slices midway between the apex and the 
base with an ocular micrometer atfour random but diametric 
points. Wall thickness was also measured in paraffin sections 
from perfusion fixed hearts containing procainamide to ensure 
relaxed state fixation of the muscle (22). The results from two 
procedures were not different. 
Vitamin E supplementation. Animals in both the sham as 
well as the banded groups were further divided in two sub- 
groups. One subgroup in each category received vitamin E 
implants and the other did not. Guinea pigs were implanted 
with subcutaneous, timed-release vitamin E (synthetic alpha- 
tocopherol) pellets (Innovative Research of America). Each 
pellet was composed of vitamin E, in lactose, cholesterol and 
methyl cellulose matrix, designed to release auniform dose of 
-6  mg (6 IU) of the vitamin per day. The pellets were placed 
in the posterior aspect of the neck at the time of thoracic 
surgery. Animals were then randomly picked at 10 weeks for 
various tudies, and the remainder were used at 20 weeks. 
Vitamin E analysis. Hearts were freeze clamped and 
stored in liquid nitrogen until analyzed by the high perfor- 
mance liquid chromatography method escribed by Lang et al. 
(23). Heart tissue was weighed and homogenized in 1 ml of 
0.1 tool/liter aqueous sodium dodecyl sulfate and 2 ml of water. 
The sample was transferred toa 10-ml test tube and fitted with 
a Teflon-lined screw cap. The homogenizer was rinsed with 
2 ml of reagent alcohol, which was combined with the homog- 
enate. The mixture was vortexed for 30 s and 2 ml of hexane 
was added. The tubes were capped and vortexed for 2 rain and 
then centrifuged for 5 min at 1,000g to separate the layers. One 
milliliter of the hexane layer was transferred toa small vial and 
dried by nitrogen. The residue was redissolved in 0.5 ml of 
reagent alcohol. The samples were analyzed by high perfor- 
mance liquid chromatography immediately after preparation. 
Different components ofthe Beckman Gold high performance 
liquid chromatography s stem used included a model 116 
programmable solvent delivery system, a model 166 program- 
mable detector module, an Altex injector system, and a 
Brownlee Silica Spheri-5 (25 cm × 4.6 mm) column. The 
mobile phase consisted of 1:9 (vol/vol) methanol/reagent alco- 
hol containing 20 mmol/liter of lithium perchlorate. The 
solvent flow rate was 1.0 ml/min and the injected volume was 
20/A. Using an ultraviolet detector at 275 nm, the area under 
the peak was recorded and compared with an external standard 
of alpha-tocopherol (Sigma). 
Antioxidant enzymes and lipid peroxidation assays. Super- 
oxide dismutase activity in the hearts was determined by the 
method previously described by Marklund (24). The hearts 
were homogenized (1:10) in 50 mmol/liter of Tris-HC1, pH 
8.20, containing 1 retool/liter of diethylenetriamine pentaacetic 
acid. The homogenate was centrifuged at 20,000g for 20 rain. 
Superoxide dismutase activity in the supernatant was deter- 
mined by following the inhibition of pyrogallol autooxidation. 
The assay is highly reproducible, and the standard curve was 
linear up to 250/~g of protein with a correlation coefficient of 
0.998 (8). Glutathione peroxidase (GSHPx) activity was deter- 
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Table 1. Ventricle and Body Weight Changes in Guinea Pigs at 10 and 20 Weeks of Aortic Banding, 
With and Without Vitamin E Treatment 
Animal Group VW (g) BW (g) VW/BW x 1,000 LVWT (mm) 
10.wk group 
Sham 1.92 _+ 0.06 760 _+ 14 2.52 _+ 0.04 4.5 + 0.2 
Banded 2.57 + 0.13" 751 _+ 16 3.42 + 0.05* 6.1 + 0.3* 
Sham+VE 1.96 : OAt 769 _+ 15 2.55 + 0.07 4.4 ± 0.2 
Banded+VE 2.55 - 0.13' 734 +_ 19 3.47 ± 0.05* 6.1 ± 0,2* 
20-wk group 
Sham 2.34 +_ 0.12 928 +_ 26 2.52 +_ 0.05 4.7 ~_ 0.2 
Banded 3.63 +_ 0.14"? 854 _+ 31 4,25 + 0.06'? 5.3 ± 0.1*t 
Sham+VE 2.25 +_ 0.13 935 _+ 29 2,40 + 0.06 4.6 ± 0.4 
Banded+VE 3.87 _+ 0.17" 895 _+ 23 432 ± 0.09* 6.0 ± 0.3:~* 
*p < 0.05 versus corresponding sham control animal. ?p < 0.05 versus corresponding value in 10-week group. :I:p < 
0.05 versus untreated control animal in same group, Data are expressed as mean value + SE for 8 to 10 animals. BW = 
body weight; LVWT = left ventricular wall thickness; VE = vitamin E; VW ~ ventricular weight. 
mined in whole heart by a method previously described by 
Paglia and Valentine (25). The hearts were homogenized in
(1:10) 75 mmol/liter of phosphate buffer, pH 7.0. The homog- 
enate was centrifuged at 20,000g for 25 rain and the superna- 
tant was aspirated and assayed for total cytosolic GSHPx 
activity (8). For the study of catalase activity, the hearts were 
homogenized in (1:10) 50 mmol/liter of potassium phosphate 
buffer, pH 7.4. The homogenate was centrifuged at 40,000g for 
30 rain. The activity in the supernatant was determined as 
described by Clairborne (26). The lipid peroxide content in 
hearts was studied by determining the thiobarbituric acid 
reactive substances as described previously (8). 
Glntathione assay. The concentration of total glutathione 
(reduced glutathione [GSH] plus oxidized glutathione 
[GSSG]) was measured in the myocardium by the glutathione 
reductase/5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) recy- 
cling assay (27). The rate of DTNB formation is followed at 
412 nm and is proportional to the sum of GSH and GSSG 
present. Myocardial tissue was homogenized in 5% sulfosali- 
cylic acid. The tissue homogenate was centrifuged for 10 rain at 
10,000g. The supernatant was stored at 4°C until assayed. 
GSSG alone was measured by treating the sulfosalicylic acid 
supernatant with 2-vinylpyridine and triethanolamine. The 
solution was vigorously mixed and the final pH of the solution 
was determined to be between 6 and 7. After 60 min, the 
derivatized samples were assayed as described previously in the 
DTNB-GSSG reductase recycling assay. GSH values were 
calculated as the difference between total (GSSG plus GSH) 
and GSSG concentrations. Values are expressed as nanograms 
per mg of tissue weight. 
Ultrastrueture. Four hearts from each group were perfu- 
sion fixed for 15 rain and processed for electron microscopic 
examination using the techniques previously described (22). 
Briefly, midmyocardial pieces (4 to 6 mm in size) were 
obtained from four different areas of the left ventricular free 
wall between the midregion and the apex of the heart. These 
prefixed tissue pieces were immersed in 0.1 tool/liter phos- 
phate buffer, pH 7.4, containing 3% glutaraldehyde and were 
further cut into cubes <1 mm in size. The aldehyde fixation 
was continued for additional 2 h. The tissues were washed for 
1 h in the previously described phosphate buffer containing 
0.05 tool/liter of sucrose. Postfixation was performed in 2% 
OsO4 for 2 h, followed by a routine procedure for embedding 
in Epon. Ultrathin sections, placed on Formvar-coated grids, 
were stained with uranyl acetate and lead citrate and were 
examined by electron microscopy. 
Protein and statistical analysis, Proteins were determined 
by the method of Lowry et al. (28). Data are expressed as the 
mean value _+ SEM. Individual means were compared using 
the unpaired Student  test. One-way analysis of variance was 
performed to determine differences between groups, and the 
Bonferroni post-hoc test was performed to compare individual 
means. Values of p < 0.05 were considered significant. 
Resu l ts  
Assessment of hypertrophy. The animals were examined 
for body weight, ventricle weight and left ventricular wall 
thickness 10 and 20 weeks after the surgical procedure (Table 
1). Ventricle weight in both banded groups was significantly 
higher than their respective control animals. Ventricle to body 
weight ratio increased by 36% at 10 weeks postoperatively and 
by 68% at 20 weeks. Left ventricular wall thickness was 
increased by 35% at 10 weeks, although this difference be- 
tween sham and banded animals declined to 13% at 20 weeks. 
There were no clinical signs of congestive heart failure in the 
banded animals at 10 weeks. Vitamin E treatment did not have 
significant effect on these variables in the 10-week group. 
However, in the 20-week banded group, left ventricular wall 
thickness in the vitamin E-treated group was significantly 
higher than in the untreated banded group. 
At 20 weeks, untreated banded animals showed evidence of 
dyspnea, an enlarged abdomen and cyanosis of the limbs and 
ear pinnae. These animals were also torpid and, at death, 
showed hydrothorax, ascites and congested liver and lungs. 
The mortality rate at 20 weeks in the banded group was 55%. 
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Table 2. Effects of Vitamin E Treatment on Hemodynamic Function in Guinea Pigs 10 and 20 Weeks 
After Operation 
AoP (ram Hg) LVP (mm Hg) 
Animal Group Syst Diast Peak Syst End Diast 
10-wk group 
Sham 76.4 _+ 3.2 58.3 + 2.1 77.5 + 2.2 5.2 ± 1.1 
Banded 94.6 _+ 2.1" 75.6 _+ 2.4* 138.4 _+ 1.4 5.7 ± 1.4 
Sham+VE 74.4 _+ 2.6 60.4 _+ 3.3 75.9 _+ 3.2 5.4 + 2.3 
Band+VE 91.8 + 4* 64.6 _+ 2.4 137.6 ± 4.4* 6.3 _+ 1.2 
20-wk group 
Sham 76.7 -+ 3.4 54.3 _+ 1.2 80.4 +_ 2.1 5.4 _+ 0.4 
Banded 64.5 ± 2.2*? 51.1 _+ 2.3? 68.5 _+ 2.2"t 11.2 + 2.1*t 
Sham+VE 78.4 _+ 3.1 59.4 + 4.3 80.4 + 2.1 5.4 +_ 0.2 
Band+VE 85.2 _+ 2.1:~ 66.2 _+ 4.2 131.7 _+ 9.1~* 6.1 _+ 1.1:~ 
*p < 0.05 versus corresponding sham control animal, tP < 0.05 versus corresponding value in 10-week group. ~:p < 
0.05 versus untreated control animal in same group. Data are expressed as mean value _+ SE for six to eight experiments. 
AoP = aortic pressure; Diast = Diastolic; LVP = left ventricular pressure; Syst = systolic; VE = vitamin E. 
There was significantly less mortality (31%) in the banded 
animals treated with vitamin E, and the survivors of this group 
at 20 weeks showed no clinical signs of heart failure. Thus, 
dyspnea nd cyanosis of the extremities were not observed and, 
at death at 20 weeks, no edema was seen in the chest or 
abdomen of the vitamin E-treated animals. 
Hemodynamie assessment. Animals were examined for left 
ventricular function (LVSP, LVEDP) and aortic pressures at 
10 and 20 weeks after the operation (Table 2). At 10 weeks, 
LVSP increased significantly. At 20 weeks of banding, LVSP 
decreased significantly, and as a result there was a very small 
pressure gradient from the ventricle to the aorta. Although no 
change was observed in LVEDP at 10 weeks, the pressure was 
increased significantly at 20 weeks. Both systolic and diastolic 
aortic pressures were significantly higher in the 10-week group. 
In the 20-week banded animals, systolic blood pressure was 
significantly lower than that in sham control animals, and there 
was no difference in the diastolic blood pressure values. 
Hemodynamic function was not influenced significantly in 
vitamin E-treated banded animals at 10 weeks. However, in 
the 20-week vitamin E-treated group, LVSP, LVEDP and 
blood pressure readings were maintained, and these values 
were comparable to those of the untreated 10-week banded 
group. 
Oxidative stress. Antioxidant enzymes. In an earlier study 
of this experimental model, it was reported that superoxide 
dismutase (SOD) and GSHPx activities increased at 10 weeks 
in the banded animals (8). These findings were confirmed in 
the present study. In the untreated banded animals, myocardial 
SOD and GSHPx activities were significantly less in the 
20-week group than in the 10-week group (Table 3). Catalase 
activity did not change in any of the groups. Vitamin E 
treatment did not have significant effect on antioxidant enzyme 
activities in either the 10- or 20-week banded group (Table 3). 
Thus, SOD and GSHPx activities within the 10- and 20-week 
groups with or without vitamin E treatment were not different 
from each other. 
Vitamin E content. The vitamin E content in the hearts was 
measured by quantitating the alpha-tocopherol c ntent by high 
performance liquid chromatography. The myocardial vitamin 
E content was not different in untreated sham control and 
banded animals at 10 and 20 weeks after the operation (Table 
4). Supplementation f vitamin E resulted in more than a 
twofold increase in the 10-week sham group and a fivefold 
increase in the 20-week sham group (Table 4). The vitamin E 
content was also increased in the 10- and 20-week banded 
groups, but the gain was much less as compared with that seen 
in the sham groups. 
Table 3. Myocardial Antioxidant Enzyme Activities at 10 and 20 Weeks of Banding of Ascending 
Aorta in Guinea Pigs With and Without Vitamin E Treatment 
10Weeks 20Weeks 
Antioxidant Enzyme -VE  +VE -VE  +VE 
SOD (U/rag protein) 18.0 _+ 3.1 16.2 _+ 2.2 11.0 + 2.1' 10.1 + 4.2 
GSHPx (nmol/mg protein) 58.3 _+ 3.3 53.1 _+ 4.1 40.9 + 5.3* 35.6 + 3.1" 
Catalase (U/mg protein) 44.9 _+ 2.4 40.5 _+ 4.3 39.9 ± 3.1 35.2 _+ 4.3 
*Significantly different (p < 0.05) from the corresponding value in the 10-week group. Data are expressed as mean 
value _+ SE for five to six experiments. GSHPx = glutathione peroxidase; SOD = superoxide dismutase; -VE  = without 
vitamin E; +VE = with vitamin E. 
510 DHALLA ET AL. JACC Vol. 28, No. 2 
OXIDATIVE STRESS AND HEART FAILURE August 1996:506-14 
Table 4. Myocardial Alpha-Tocopherol, Glutathione and Thiobarbituric Acid Reactive Substances at10 and 20 Weeks of Banding of 
Ascending Aorta in Guinea Pigs With and Without Vitamin E Treatment 
10 Weeks 20 Weeks 
Without VE With VE Without VE With VE 
No. of 
Myocardial Content Expts Sham Banded Sham Banded Sham Banded Sham Banded 
Alpha-tocopherol 5-6 0.38 -+ 0.01 0.43 +_ 0.05 1.04 +__ 0.1' 0.78 +_ 0.02'I 0.37 _+ 0.01 0.46 + 0.06 2.08 + 0.11'~ 0.99 +_ 0.04*t§ 
(/zmol/g wet wt) 
GSH (ng/mg wet wt) 5-8 218 _+ 10 354 _+ 14§ 280 + 8* 350 -+ 7§ 358 + 15:~ 267 _+ 10:~§ 349 + 10 321 _+ 13" 
GSSG (ng/mg wet wt) 6-8 55 -+ 6 42 +_ 5 38 _+ 7 42 _+ 4 62 _+ 10 116 -+ 8:I:§ 51 _+ 4 58 _+ 5* 
GSH/GSSG ratio 4 8.4§ 7.4* 8.5 5.8 2.3:~§ 6.9 5.5* 
TBARS (nmol/g 6-7 81 _+ 12 61 +_ 5§ 68 --_ 6 58 +- 7 81 _+ 8 82 + 95 65 -+ 5 67 -4- 4* 
wet wt) 
*p < 0.05 versus untreated control animal in the same group, tP < 0.05 versus corresponding vitamin E (VE)-treated sham control animal. ~p < 0.05 versus 
corresponding value in 10-week group. §p < 0.05 versus corresponding sham control animal. Data are expressed asmean value + SE for number of experiments (Expts). 
GSH = reduced glutathione; GSSG = oxidized glutathione; TBARS = thiobarbituric acid reactive substances. 
Redox state. There was a significant age-dependent in- 
crease in the GSH content in the 20-week sham control 
animals. GSH activity increased by 62% in the 10-week banded 
group and decreased by 25% in the 20-week banded group as 
compared with their respective sham control animals (Table 
4). The GSSG content at 10 weeks was not significantly 
different in banded and control animals (Table 4). However, an 
increase >100% in the GSSG content was seen in the 20-week 
banded group as compared with the control animals. The 
redox ratio (GSH/GSSG) was significantly increased in the 
10-week banded group and was decreased in the 20-week 
banded group as compared with their respective sham control 
animals (Table 4). Vitamin E treatment increased the GSH 
content in the 10-week sham treated group, whereas the 
10-week banded treated group showed no change. In the 
20-week banded treated group (Table 4), GSH was higher as 
compared with respective untreated control animals. The 
GSSG content was decreased significantly in the 20-week 
banded vitamin E-treated animals as compared with the 
20-week untreated group (Table 4). Vitamin E treatment 
significantly improved the redox ratio in the 20-week banded 
group (Table 4). 
Lipid peroxidation. Thiobarbituric acid reactive substances 
(TBARS) were 25% less in the 10-week banded group than in 
its sham control group (Table 4). There was no difference in 
the myocardial TBARS content between the 20-week control 
group and the banded group. However, TBARS in the 20-week 
banded group were significantly greater than in the 10-week 
banded hearts. Vitamin E treatment in banded animals ignif- 
icantly reduced lipid peroxidation at 20 weeks as compared 
with the untreated group (Table 4). 
Ultrastructure. Sham control hearts showed normal ultra- 
structure, including compact myocytes, myofibrils having the 
typical appearance of A and I bands, T tubules and a sarco- 
plasmic reticulum system (Fig. 1). Mitochondria in the control 
hearts were generally normal with a moderately dense matrix. 
The Golgi membranes were seen in the polar regions of the 
nucleus. There were no signs of intracellular or interstitial 
edema. The ultrastructural details of myocytes in 10-week 
banded hearts appeared normal and were not different from 
Figure 1. Electron micrograph of a control guinea pig 
heart demonstrating ormal ultrastructure: sarcomeres 
(S), T tubules (arrowheads) and mitochondria (M). 
Bar = I/~m. 
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Figure 2. Electron micrographs from a 20-week failing 
guinea pig heart. Top, Ultrastructural injury is character- 
ized by the loss of myofibrils, mitochondrial damage, 
intracellular edema nd loss of a typical sarcomere ar- 
rangement. Bottom, Vacuolization aswell as mitochon- 
drial damage ingreater detail. Bars = 1/zm. 
the sham control hearts. However, some deposition of collagen 
fibers around the blood vessels as well as the interstitial spaces 
was observed. Hearts from the 20-week banded group did not 
show a normal ultrastructure owing to increased vacuolization 
as well as mitochondrial injury (Fig. 2A). Loss of contractile 
elements, as well as intracellular edema, was apparent. At a 
higher magnification, mitochondrial injury was characterized 
by a dropout of cristae membranes (Fig. 2B). Treatment with 
vitamin E improved the ultrastructure of cardiomyocytes in the 
20-week banded group (Fig. 3). Vacuolization, mitochondrial 
injury as well as intracellular edema ppeared to be less in the 
20-week banded group treated with vitamin E (Fig. 3). Al- 
though complete protection of the ultrastructure was not seen 
with vitamin E treatment, there was an obvious reduction in 
the injury as compared with the 20-week banded untreated 
hearts. 
Discuss ion 
Compensated hypertrophy and heart failure. Several fac- 
tors have been suggested to play a role in the transition from 
compensated heart hypertrophy to a decompensated stage, 
leading to the clinical symptoms of congestive heart failure. 
These include abnormalities in excitation-contraction cou- 
pling, calcium handling, contractile proteins, sympathetic sup- 
port mechanisms and diastolic function (29,30). The exact 
cause of heart failure still remains elusive and may actually be 
a result of a combination of many factors. The present study 
provides evidence, for the first time, that vitamin E therapy 
delays the development of heart failure associated with the 
condition of increased oxidative stress. Furthermore, the ben- 
eficial effect afforded by vitamin E may be attributable to its 
antioxidant properties, as was suggested by both an improved 
redox state and reduced lipid peroxidation. Although vitamin 
E treatment improved the hemodynamic function as well as 
the survival rate, there was still a significant degree of hyper- 
trophy and mortality in this group. There is no immediate and 
definitive explanation for the mortality in the vitamin 
E-treated group. Sudden death in a sustained chronic hyper- 
trophy condition remains a possibility. Patients with hypertro- 
phic cardiomyopathy show a higher incidence of sudden death, 
although the range of clinical spectrum in these individuals 
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Figure 3. Electron micrograph from a 20-week banded, 
vitamin E-treated guinea pig heart. Vacuolization as
well as mitochondrial damage is significantly less. Con- 
tractile lements a well as general cellular organization 
were better maintained in this group. Bar = 1 p.m. 
varies and may include the asymptomatic form to sudden death 
as an initial presentation (31). 
In the present study, a chronic model of gradually increas- 
ing pressure overload was used to induce heart hypertrophy 
that progresses into failure (21). Hyperfunctional hypertrophy 
without heart failure at 10 weeks in this study was indicated by 
a symmetric ncrease in left ventricular wall thickness as well as 
increases in ventricle to body weight ratio, aortic pressure and 
LVSP with no change in LVEDP. Although total ventricle 
weight increased further at 20 weeks, left ventricular wall 
thickness was decreased. Thus, thinning of the left ventricular 
wall at 20 weeks suggests dilation or remodeling ofthe heart at 
this stage. Congestive heart failure in the 20-week banded 
group was indicated by left ventricular dilation, depressed 
LVSP, increased LVEDP, ascites and dyspnea. Depressed 
myocardial function, thinning of the left ventricular wall and 
ultrastructural changes in the myocardium, taken together, 
provide a strong indication of myocardial bnormalities. In any 
case, the stages of compensated hypertrophy at10 weeks and 
congestive heart failure at 20 weeks in the banded groups were 
clearly established. An increase in endogenous antioxidant 
enzyme activities in the hypertrophied hearts, with a concom- 
itant decrease in lipid peroxidation and an increase in the 
redox ratio, suggests that heart hypertrophy at 10 weeks was 
accompanied by a reduction in oxidative stress, although the 
opposite was true in the failing hearts at 20 weeks. 
Oxidative stress and myocardial dysfunction. Despite the 
lack of difference in the myocardial vitamin E levels in the 10- 
and 20-week untreated banded groups, an increase in the 
oxidative stress in the 20-week banded group was suggested by 
several other observations made in this study. These included 
a significant decrease in the antioxidant enzyme activities, a
decrease in the GSH/GSSG ratio and an increase in TBARS 
during heart failure in the 20-week banded group as compared 
with the nonfailing 10-week banded group. Although these 
observations suggest that increased oxidative stress and thus 
failure in the 20-week banded group were not due to vitamin E 
deficiency per se, vitamin E supplementation modulated these 
abnormalities. 
The suggestion that a relative increase in oxidative stress 
was contributing to the pathogenesis of heart failure was 
supported by the fact that banded animals upplemented with 
vitamin E maintained better hemodynamic function at 20 
weeks. Vitamin E is a naturally occurring antioxidant that 
helps stabilize biologic membranes (14). Polyunsaturated fatty 
acids in the membranes are highly susceptible to oxidation by 
endogenously produced free radicals. Vitamin E, because of its 
lipid solubility, is available in the lipid phase and is very 
effective in offering protection (14). The exact mechanism of 
vitamin E protection is unknown. However, vitamin E is 
considered to react directly with partially reduced forms of 
oxygen, yielding vitamin E radical and lipid hydroperoxides, 
which can be removed by phospholipase-GSHPx systems (32). 
This not only interrupts the radical chain reaction that propa- 
gates the peroxidation of membranes, but it may also have a 
sparing effect on the GSHPx system, thereby improving the 
GSH/GSSG ratio seen in the 20-week vitamin E-treated heart. 
Vitamin E has also been shown to be an effective antioxidant 
against free radical-induced injury in in vivo conditions 
(15,16,20). In contrast, animals put on a vitamin E-deficient 
diet were reported to be more prone to catecholamine- as well 
as adriamycin-induced cardiomyopathies, and both of these 
conditions are known to be mediated by free radical action 
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(19,20). In animals with vitamin E deficiency, myopathy of the 
heart muscle is frequently seen (33). 
As a cosubstrate of glutathione peroxidase, GSH plays an 
essential role against oxygen free radicals and prevents the 
peroxidation of membrane lipids (34). This protective mecha- 
nism results in an increased rate of the intracellular, oxidized 
glutathione formation. The changes in glutathione status pro- 
vide important information on the cellular oxidative events, 
tissue accumulation a d release of GSSG, and this status has 
been used as a sensitive index of oxidative stress (2,34-36). An 
increased redox state seen in the 10-week banded group 
suggests less oxidative stress at this stage. However, during the 
heart failure stage, the redox state was decreased and the 
change was mainly due to increased GSSG accumulation. This 
suggests increased oxidative stress in the 20-week failing group. 
Vitamin E treatment significantly improved the redox ratio in 
the failing animals. By interrupting lipid radical chain reac- 
tions, vitamin E reduces lipid peroxides as well as the forma- 
tion of GSSG. In this regard, a significant reduction in GSSG 
levels in vitamin E-treated hearts at 20 weeks was seen in this 
study. 
Normally, endogenous antioxidants help protect he cell 
against free radical injury. However, these protective mecha- 
nisms may be compromised during the conditions of increased 
oxidative stress (2,5,36). Increased oxidative stress during the 
failure stage in the present study was indicated by a decrease in
the GSH/GSSG ratio as well as by depressed activities of 
GSHPx and SOD. In this regard, increased production of free 
radicals has been shown in mitochondria isolated from hyper- 
trophied as well as failing hearts (11,37). Lipid peroxidation i
cardiomyopathic earts was also reported to increase in ham- 
sters (11). 
Vitamin E and heart failure in patients. It has been shown 
that patients with ischemic heart disease have higher plasma 
lipid peroxide concentrations than control subjects (38). An 
increase in the breath pentane content in patients with chronic 
heart failure (13) as well as coronary artery disease suggests 
increased lipid peroxidation (12,39). Breath pentane was sig- 
nificantly lowered in chronic heart failure patients maintained 
on free radical scavengers (13). Inhibition of peroxidation by 
vitamin E might favorably influence the balance between 
peroxidative damage and the repair mechanisms of the body. 
Two separate studies provide evidence for an association 
between a high intake of vitamin E and a reduced risk of 
coronary artery disease in both men and women (40,41). 
Increased lipid peroxidation, as well as higher levels of pentane 
in exhaled air, has also been correlated with reduced levels of 
vitamin E (12,13). In a recent study, administration f different 
antioxidants, including vitamin E, in patients with acute myo- 
cardial infarction within 24 h after the onset of symptoms, was 
reported to improve several cardiac end points, including 
cardiac death (42). These data from humans provide a strong 
indication for the beneficial role of vitamin E as an antioxidant. 
Because vitamin E treatment did not affect other myocar- 
dial enzymatic antioxidants in the present study, the beneficial 
effect is most likely the result of a direct antioxidant effect. 
Relatively less accumulation of vitamin E in the banded 
animals, at both 10 and 20 weeks, as compared with the sham 
control animals, may be a reflection of either altered metabo- 
lism or an increase in the utilization of vitamin E in these 
hearts. The latter possibility may be more plausible in the 
failing hearts that had reduced enzymatic antioxidant reserve. 
Conclusions. A decrease inantioxidants and an increase in 
oxidative stress during the failure stage, as well as a delay in the 
pathogenesis of heart failure by vitamin E treatment, together 
indicate that heart failure may be the result of a mismatch 
between oxygen radical production and the available antioxi- 
dant reserve in the heart. The study suggests a potential 
beneficial role of antioxidant therapy in modulating the patho- 
genesis of heart failure. 
References  
1. Braunwald E. The definition of heart failure. Eur Heart J 1983;4:446-7. 
2. Ferrari R, Ceconi C, Curello S, et al. Oxygen-mediated myocardial damage 
during ischemia nd reperfusion: role of the cellular defenses against oxygen 
toxicity. J Mol Cell Cardiol 1985;17:937-45. 
3. Blaustein A, Shine L, Brooks WW, Fanburg BL, Bing OHL. Influence of 
exogenously generated oxidant species on myocardial function and contrac- 
tile failure. Am J Physiol 1986;250:H595-H599. 
4. Lee V, Randhawa AK, Singal PK. Adriamycin-induced myocardial dysfunc- 
tion in vitro is mediated by free radicals. Am J Physio11991;261:H989-H995. 
5. Singal PK, Kirshenbaum LA. A relative deficit in antioxidant reserve may 
contribute in cardiac failure. Can J Cardiol 1990;6:47-9. 
6. Kanter MM, Hamlin RL, Unverferth DV, Davis HW, Merola AJ. Effect of 
exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. 
J Appt Physiol 1985;59:1298-1303. 
7. Gupta M, Singal PK. Higher antioxidant capacity during chronic stable heart 
hypertrophy. Circ Res 1989;64:398-406. 
8. Dhalla AK, Singal PK. Antioxidant changes in hypertrophy and failing 
guinea pigs hearts. Am J Physiol 1994;267:H1280-H1285. 
9. Kirshenbaum LA, Singal PK. Antioxidant changes in heart hypertrophy: 
significance during hypoxia-reoxygenation njury. Can J Physiol Pharmacol 
1992;70:1330-5. 
10. Kirshenbaum LA, Singal PK. Increase in endogenous antioxidant enzymes 
protects the heart against reperfusion i jury. Am J Physiol 1993;265:H484- 
H493. 
11. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamaazaki 
N. Effects of verapamil on experimental cardiomyopathy in the bio 146 
Syrian hamster. J Am Coll Cardiol 1987;10:1128-34. 
12. Lemoyne BF, Van Gossum A, Kurian R, Ostro M, Axler J, Jeejeebhoy KN. 
Breath pentane analysis as an index of lipid peroxidation: a functional test of 
vitamin E status. Am J Clin Nutr 1987;46:267-72. 
13. Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ. 
Elevated breath pentane in heart failure reduced by free radical scavenger. 
Free Radic Biol Med 1993;14:643-7. 
14. Lucy JA. Functional and structural aspects of biological membranes: a 
suggested structural role of vitamin E in control of membrane permeability 
and stability. Ann N Y Acad Sci 1972;203:4-11. 
15. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. 
Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor 
response. Science 1977;19:165-7. 
16. Massey KD, Burton KP. Alpha-tocopherol attenuates myocardial 
membrane-related alterations resulting from ischemia nd reperfusion. Am J 
Physiol 1989;256:H1192-Hl199. 
17. Steiner M, Mower R. Mechanism of action of vitamin E on platelet function. 
Ann N Y Acad Sci 1982;393:289-99. 
18. Klein HH, Pich S, Lindert S, Nebandahl K, Niedmann P, Kreuzer H. 
Combined treatment with vitamins E and C in experimental myocardial 
infarction in pigs. Am Heart J 1989;118:661-73. 
19. Singal PK, Tong J. Vitamin E deficiency accentuates adriamycin-induced 
cardiomyopathy and cell surface changes. Mol Cell Biochem 1988;84:163-71. 
5]4  DHALLA ET AL. JACC Vol. 28, No. 2 
OXIDATIVE STRESS AND HEART FAILURE August 1996:506-14 
20. Singal PK, Beamish RE, Dhalla NS. Potential oxidative pathways of cat- 
echolamines in the formation of lipid peroxide and genesis of heart disease. 
Adv Exp Med Biol 1983;161:391-401. 
21. Randhawa AK, Singal PK. Pressure overload-induced cardiac hypertrophy 
with and without dilation. J Am Coll Cardiol 1992;20:1569-75. 
22. Singal PK, Dhalla NS. Morphological methods for studying heart mem- 
branes. In: Dhalla NS, editor. Methods in Studying Cardiac Membranes. vol. 
II. Boca Raton (FL): CRC Press, 1984:3-16. 
23. Lang JK, Gohil K, Packer L. Simultaneous determination f tocopherols, 
ubiquinols and ubiquinones in blood, plasma, tissue homogenates and 
subcellular f actions. Anal Biochem 1986;157:106-16. 
24. Marldund SL. Pyrogallol autooxidation. In: Greenwald RA, editor. Hand- 
book of Methods for Oxygen Radical Research. Boca Raton (FL): CRC 
Press, 1985:243-7. 
25. Paglia DE, Valentine WN. Studies on the quantitative and qualitative 
characterization f erythrocyte glutathione peroxidase. J Lab Clin Med 
1967;70:158-69. 
26. Clairbome A. Catalase activity. In: Greenwald RA, editor. Handbook of 
Methods for Oxygen Radical Research. Boca Raton (FL): CRC Press, 
1985:283-4. 
27. Anderson ME. Determination of glutathione and glutathione disulfide in 
biological samples. Methods Enzymol 1985;113:548-55. 
28. Lowry OH, Rosenbrough NT, Farr AL, Randall AT. Protein measurements 
with the Folin phenol reagent. J Biol Chem 1951;193:265-75. 
29. Katz AM. The myocardium in congestive heart failure. Am J Cardiol 
1989;63:12A-16A. 
30. Dhalla NS, Pierce GN, Panagia V, Singal PK, Beamish RE. Calcium 
movements in relation to heart function. Basic Res Cardiol 1982;77:11%39. 
31. Cannan CR, Reeder GS. Hypertrophic cardiomyopathy: who is at risk? ACC 
Curr J Rev 1996;5:63-4. 
32. McCay PB, King MM. Vitamin E: its role as a biologic free radical scavenger 
and its relationship to the microsomal mixed-function oxidase system. In: 
Machlin LJ, editor. Vitamin E: A Comprehensive Treatise. vol. 1. New York: 
Marcel Dekker, 1980:289-317. 
33. Bauernfeind J. Tocopherols in food. In: Machlin LJ, editor. Vitamin E: A 
Comprehensive Treatise. Vol. 1. New York: Marcel Dekker, 1984:99-145. 
34. Ferrari R, Ceconi C, Curello S, Cargnoni A, Medici D. Oxygen-free radicals 
and repeffusion i jury: the effects of ischemia nd repeffusion on the cellular 
ability to neutralize oxygen toxicity. J Mol Cell Cardiol 1986;18:67-9. 
35. Curello S, Ceconi C, Medici D, Fcrrari R. Oxidative stress during myocardial 
ischemia nd repeffusion: experimental and clinical evidence. J Appl Cardiol 
1986;1:311-27. 
36. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the 
heart. J Pharmacol Toxicol Methods 1993;30:55-67. 
37. Guarnieri C, Muscari C, Caldarera CM. Oxygen radicals and tissue damage 
in heart hypertrophy. In: Harris P, Poole-Wilson PA, editors. Advances in 
Myocardiology. Vol. 5. New York: Plenum, 1985:191-9. 
38. Stringer MD, G6r6g PG, Freeman A, Kakkar VV. Lipid peroxides and 
atherosclerosis. BMJ 1989;298:28l-4. 
39. Weitz ZW, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. High breath 
pentane concentrations during acute myocardial infarction. Lancet 1991;337: 
933-5. 
40. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett 
WC. Vitamin E consumption and the risk of coronary disease in men. N Engl 
J Med 1993;328:1450-6. 
41. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett 
WC. Vitamin E consumption and the risk of coronau, disease in women. 
N Engl J Meal 1993;328:1444-9. 
42. Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of antioxidant 
vitamins in suspected acute myocardial infarction (The Indian Experiment of 
Infarct Survival-3). Am J Cardiol 1996;77:232-6. 
